Patients with blood cancers will have new treatment options in addition to stem cell transplants now available at the Upstate Cancer Center. Jeffrey Pu, MD, PhD, and clinical leader Meghan Lewis, RN,  tell about the addition of allogeneic stem cell transplants and CAR T-cell therapy. Allogeneic stem cell transplants use stem cells from donors. T-cells are a type of white blood cells, and chimeric antigen receptor T-cell therapy is a process in which the patient's own T-cells are engineered to better attack cancer cells.